Davidson Michael H.
SEC-identified person · CIK 1573785 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bioage Labs, Inc. BIOA | Director | filed 2024 - 2026 |
| Newamsterdam Pharma Co N.V. NAMS | Director · Chief Executive Officer | filed 2023 - 2026 |
| Tenax Therapeutics, INC. tenx | Director | filed 2021 - 2026 |
| Silence Therapeutics plc SLN | Director | filed 2025 - 2025 |
| Phase III Medical INC/DE PHSM | Director | filed 2020 - 2022 |
| Omthera Pharmaceuticals, Inc. OMTH | Executive VP & CMO | filed 2013 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.